Implication of expression of Nanog in prostate cancer cells and their stem cells

Abstract

Recent studies suggested that the prostate cancer may arise from prostate cancer stem cells that share some same characteristics with normal stem cells. The purpose of this study was to detect the differences of Nanog expression between PC3 prostate cancer cell line and its tumor stem cells, and the relationship was preliminarily examined between Nanog and prostate cancer and its tumor stem cells. By using magnetic active cell sorting (MACS), we isolated a population of CD44⁺/CD133⁺ prostate cancer cells that display stem cell characteristics from PC3 cell line. Immunohistochemistry revealed positive expressions of CD44, CD133 and α₂β₁-integin in the isolated cells. CCK-8 analysis showed that isolated cells had a strong proliferative ability. The formation of the cell spheres in serum-free medium and holoclones in serum-supplied medium showed that the cells were capable of self-renewing, indicating that the isolated cells were a population of cancer stem-like cells derived from PC3 cell line. Western blotting exhibited that the isolated cells had higher experession of Nanog, an embryonic stem marker, as compared with PC3 cells. Our study showed that Nanog might be helpful in sustaining the self-renewal and the undifferentiation of prostate cancer stem cells, and may serve as a marker for prostate cancer stem cells for isolation and identification.

Keywords

Nanog / prostate cancer / cancer stem cells

References

[1] GibbsC.P., KukekovV. G., ReithJ. D., et al.. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 2005, 7(11): 967-976

[2] Al-HajjM., WichaM.S., Benito-HernandezA., et al.. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 2003, 100(7): 3983-3988

[3] SinghS.K., HawkinsC., ClarkeI.D., et al.. Identification of human brain tumour initiating cells. Nature, 2004, 432(7015): 396-401

[4] KimC.F., JacksonE.L., WoolfendenA.E., et al.. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 2005, 121(6): 823-835

[5] HopeK.J., JinL., DickJ.E.. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol, 2004, 5(7): 738-743

[6] ReyaT., MorrisonS.J., ClarkeM.F., et al.. Stem cells, cancer, and cancer stem cells. Nature., 2001, 414(6859): 105-111

[7] JordanC.T.. Cancer stem cell biology: from leukemia to solid tumors. Curr Opin Cell Biol, 2004, 16(6): 708-712

[8] CollinsA.T., BerryP.A., HydeC., et al.. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 2005, 65(23): 10946-10951

[9] PfeifferM.J., SchalkenJ.A.. Stem cell characteristics in prostate cancer cell lines. Eur Urol, 2010, 57(2): 246-254

[10] PatrawalaL., CalhounT., Schneider-BroussardR., et al.. Highly purified CD44⁺ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene, 2006, 25(12): 1696-1708

[11] MitsuiK., TokuzawaY., ItohH., et al.. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 2003, 113(5): 631-642

[12] ChambersI., ColbyD., RobertsonM., et al.. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 2003, 113(5): 643-655

[13] LinT., ChaoC., SaitoS., et al.. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol, 2005, 7(2): 165-171

[14] HartA.H., HartleyL., ParkerK., et al.. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer, 2005, 104(10): 2092-2098

[15] Hoei-HansenC.E., SehestedA., JuhlerM., et al.. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol, 2006, 209(1): 25-33

[16] Ben-PorathI., ThomsonM.W., CareyV.J., et al.. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet, 2008, 40(5): 499-507

[17] GibbsC.P., KukekovV.G., ReithJ.D., et al.. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 2005, 7(11): 967-976

[18] LiH., ChenX., Calhoun-DavisT., et al.. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res, 2008, 68(6): 1820-1825

[19] PatrawalaL., Calhoun-DavisT., Schneider-BroussardR., et al.. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44⁺alpha2beta1⁺ cell population is enriched in tumor-initiating cells. Cancer Res, 2007, 67(14): 6796-6805

[20] HurtE.M., KawasakiB.T., KlarmannG.J., et al.. CD44+ CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer, 2008, 98(4): 756-765

[21] DontuG., AbdallahW.M., FoleyJ.M., et al.. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev, 2003, 17(10): 1253-1270

[22] LeeJ., KotliarovaS., KotliarovY., et al.. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 2006, 9(5): 391-403

[23] LiH., JiangM., HonorioS., et al.. Methodologies in assaying prostate cancer stem cells. Methods Mol Biol, 2009, 568: 85-138

[24] VanderG.D., KarthausW.L., DalrympleS., et al.. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res, 2008, 68(23): 9703-9711

[25] RichardsonG.D., RobsonC.N., LangS.H., et al.. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci, 2004, 117(Pt16): 3539-3545

[26] WangS.H., TsaiM.S., ChiangM.F., et al.. A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells. Gene Expr Patterns, 2003, 3(1): 99-103

[27] BoothH.A., HollandP.W.. Eleven daughters of NANOG. Genomics, 2004, 84(2): 229-238

[28] ZhouS., LiF., XiaoJ., et al.. Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs. J Huazhong Univ Sci Technolog [Med Sci], 2010, 30(1): 81-84